These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26152274)

  • 21. Intra-operative use of one-step nucleic acid amplification (OSNA) for detection of the tumor load of sentinel lymph nodes in breast cancer patients.
    Heilmann T; Mathiak M; Hofmann J; Mundhenke C; van Mackelenbergh M; Alkatout I; Wenners A; Eckmann-Scholz C; Schem C
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1649-55. PubMed ID: 23907595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
    Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hookwire-guided Sentinel Lymph Node Biopsy Using Contrast-enhanced Ultrasonography Followed by a One-step Nucleic Acid Amplification (OSNA) Assay for Breast Cancer.
    Miyake T; Shimazu K; Tanei T; Naoi Y; Kagara N; Shimoda M; Kim SJ; Noguchi S
    Anticancer Res; 2019 Nov; 39(11):6183-6192. PubMed ID: 31704846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CK19 expression in breast tumours and lymph node metastasis after neoadjuvant therapy.
    Vieites B; López-García MÁ; Castilla C; Hernández MJ; Biscuola M; Alfaro L; Atienza MR; Castilla MÁ; Palacios J
    Histopathology; 2016 Aug; 69(2):239-49. PubMed ID: 26708058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic value of one-step nucleic acid amplification (OSNA) for sentinel lymph nodes in colon cancer patients.
    Vogelaar FJ; Reimers MS; van der Linden RL; van der Linden JC; Smit VT; Lips DJ; van de Velde CJ; Bosscha K
    Ann Surg Oncol; 2014 Nov; 21(12):3924-30. PubMed ID: 24912612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
    Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
    Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total Tumor Load of mRNA Cytokeratin 19 in the Sentinel Lymph Node as a Predictive Value of Axillary Lymphadenectomy in Patients with Neoadjuvant Breast Cancer.
    Peña KB; Kepa A; Cochs A; Riu F; Parada D; Gumà J
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
    Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
    Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.
    Cohen LF; Breslin TM; Kuerer HM; Ross MI; Hunt KK; Sahin AA
    Am J Surg Pathol; 2000 Sep; 24(9):1266-72. PubMed ID: 10976701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer.
    Yaguchi Y; Sugasawa H; Tsujimoto H; Takata H; Nakabayashi K; Ichikura T; Ono S; Hiraki S; Sakamoto N; Horio T; Kumano I; Otomo Y; Mochizuki H; Yamamoto J; Hase K
    Ann Surg Oncol; 2011 Aug; 18(8):2289-96. PubMed ID: 21301968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan.
    Tamaki Y; Sato N; Homma K; Takabatake D; Nishimura R; Tsujimoto M; Yoshidome K; Tsuda H; Kinoshita T; Kato H; Taniyama K; Kamio T; Nakamura S; Akiyama F; Noguchi S;
    Cancer; 2012 Jul; 118(14):3477-83. PubMed ID: 22252672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of a new system using a one-step nucleic acid amplification assay for detecting lymph node metastases in breast cancer.
    Shimazu K; Tanei T; Tamaki Y; Saeki T; Osaki A; Hasebe T; Tomita Y; Daito M; Kobayashi M; Noguchi S
    Med Oncol; 2019 May; 36(6):54. PubMed ID: 31062258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
    Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
    Breast Cancer Res Treat; 2013 May; 139(1):87-93. PubMed ID: 23576079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
    Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
    Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of sentinel lymph node metastases in cervical cancer: assessment of KRT19 mRNA in the one-step nucleic acid amplification (OSNA) method.
    Okamoto S; Niikura H; Nakabayashi K; Hiyama K; Matoda M; Takeshima N; Watanabe M; Nagase S; Otsuki T; Yaegashi N
    Gynecol Oncol; 2013 Sep; 130(3):530-6. PubMed ID: 23811115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER-2 positive patients presenting with clinically node-negative disease.
    Al-Hilli Z; Hieken TJ; Hoskin TL; Heins CN; Boughey JC
    J Surg Oncol; 2015 Oct; 112(5):453-7. PubMed ID: 26345596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients.
    Le Frère-Belda MA; Bats AS; Gillaizeau F; Poulet B; Clough KB; Nos C; Peoc'h M; Seffert P; Bouteille C; Leroux A; Guillemin F; Blanc-Fournier C; Crouet H; Arnould L; Cuisenier J; Penault-Llorca F; Gimbergues P; Jacquemier J; Houvenaeghel G; Chatellier G; Lécuru F
    Int J Cancer; 2012 May; 130(10):2377-86. PubMed ID: 21780107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative assessment of sentinel lymph nodes after neoadjuvant chemotherapy in patients with breast cancer.
    Rubio IT; Aznar F; Lirola J; Peg V; Xercavins J
    Ann Surg Oncol; 2010 Jan; 17(1):235-9. PubMed ID: 19777186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.